Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107
Sex
All sexes
Ages
Ages 2 Years to 12 Years
Primary completion
2025-12-31
Last update
2026-05-04

What this trial studies

The goal of this clinical trial is to learn about the effects of an animal-assisted resilience training in children who experienced stressful life events or who have a diagnosis of autism spectrum disorder. The main question it aims to answer is: • Is an animal-assisted resilience training a feasible approach to increase resilience in children with a history of stressful life events or a diagnosis of autism spectrum disorder? Participants will take part in 12 training sessions of a standardized resilience training. The training is group-based, takes place outdoors, and includes interactions with different animals.

Conditions in scope

  • Autism Spectrum Disorder
  • Life Change Events

Interventions

  • Animal-assisted resilience training (Behavioral) — Participants take part in 12 sessions (120 minutes each), each session focuses on a topic that is related to resilience. The intervention takes part outdoors on a farm, and includes interactions with several different animals. The training takes place in…

Who can join

All sexes · Ages 2 Years to 12 Years

Inclusion criteria

  • Age between 2 and 4 years (toddler group) or 8 and 12 years (children group)
  • History of at least one stressful life event experience OR diagnosis of autism spectrum disorder
  • Basic knowledge of either German or English of parents and child to follow the instructions during the training sessions and completion of interviews.

Exclusion criteria

  • \- Medical contraindications for contact with animals, such as allergies or phobia

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Basel University of Basel Unknown

Status & timeline

  • Overall status: Completed
  • Study type: Interventional
  • Phase: N/A
  • Start date: 2021-08-10
  • Primary completion: 2025-12-31
  • Last update posted: 2026-05-04
  • First posted: 2023-09-06

Lead sponsor: University Hospital, Basel, Switzerland (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • Questionnaire on resources in childhood and adolescence (18 weeks)
    Pre-to-post assessment changes in resilience

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06025539 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.